Machine Learning Can Predict Anti–VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema

Machine learning classifiers can predict treatment demand and may assist in establishing patient-specific treatment plans in the near future.